Cancer Research
Skin Microbiome Shifts Detected in Immunotherapy Rash Patients
A City of Hope study explores whether skin bacteria differ between rash-affected and healthy skin in cancer immunotherapy patients.
Clinical Trial
Jun 6, 2026 0
Results for "Oral Microbiome Aging" in Cancer
20 articles
Cancer Research
Sputum and Microbiome Signatures May Predict Immunotherapy Response in Lung Cancer
A completed French trial explores how gut and airway microbiota, blood, and sputum biomarkers relate to immunotherapy outcomes in metastatic NSCLC.
Clinical Trial
Jun 4, 2026 0
Cancer Research
Strength Training Fights Inflammaging in Bone Marrow Transplant Survivors
A 10-week supervised strength program targets chronic inflammation and self-efficacy in long-term allogeneic HCT survivors.
Clinical Trial
May 25, 2026 0
Cancer Research
Melanoma Drug Resistance Linked to Cellular Communication Vesicles Called Exosomes
French researchers studied how tiny cellular packages called exosomes may help melanoma cells resist treatment and spread throughout the body.
Clinical Trial
Mar 28, 2026 0
Cancer Research
Physical Therapy and Relaxation Techniques Boost Resilience in Older Lung Cancer Patients
A completed pilot trial tested physical therapy and progressive muscle relaxation to preserve function and mood in older adults with advanced lung cancer.
Clinical Trial
May 12, 2026 0
Cancer Research
Time-Restricted Eating Shows Promise for Breast Cancer Survivors Over 60
Eight-week study of weekday-only intermittent fasting in older breast cancer survivors with overweight demonstrates feasibility.
Clinical Trial
Mar 28, 2026 0
Cancer Research
Online Mindfulness Program Shows Promise for Gynecological Cancer Patients
A Swiss feasibility trial tests digital mindfulness-based cancer recovery, tracking psychosocial outcomes, medication use, and biological markers.
Clinical Trial
May 16, 2026 0
Cancer Research
Cancer Immunotherapy May Weaken Bones in Melanoma Survivors
Study examines bone density loss in melanoma patients receiving immune-boosting cancer drugs like nivolumab and pembrolizumab.
Clinical Trial
Mar 29, 2026 1
Cancer Research
AI-Guided Cancer Care Program Targets Immunotherapy Gaps in Minority NSCLC Patients
A Columbia University trial tested a digital care service to improve immunotherapy outcomes and reduce healthcare burden for minority lung cancer patients.
Clinical Trial
Jun 15, 2026 0
Cancer Research
Curcumin Added to Standard Chemo Tested in Metastatic Colorectal Cancer Trial
A Phase 2 trial explores whether oral curcumin can enhance Avastin/FOLFIRI chemotherapy outcomes in patients with unresectable colorectal metastases.
Clinical Trial
May 16, 2026 0
Cancer Research
Microfluidic Chip Detects Lung Metastasis in Osteosarcoma Using Blood Exosomes
New diagnostic chip analyzes blood exosomes to detect early lung spread of bone cancer, potentially improving treatment outcomes.
Clinical Trial
Mar 29, 2026 0
Cancer Research
PULSAR Radiation Plus IMSA101 Immunotherapy Trial in Oligoprogressive Cancers Terminated Early
A Phase 2 trial combining adaptive stereotactic radiotherapy with IMSA101 and checkpoint inhibitors was halted after enrolling only 16 patients.
Clinical Trial
May 14, 2026 0
Cancer Research
Liquid Biopsy for Sarcoma: Can cfDNA and Telomere Mutations Predict Recurrence
Researchers explored whether cancer-derived cell-free DNA and telomere maintenance mutations could serve as early warning biomarkers in soft tissue sarcoma patients.
Clinical Trial
May 16, 2026 0
Cancer Research
Turin Study Maps Why Multiple Myeloma Escapes Anti-CD38 Immunotherapy
Italian researchers track genomic and cellular changes in myeloma patients to uncover why anti-CD38 treatments stop working.
Clinical Trial
Jun 16, 2026 0
Cancer Research
Trial Tests Whether Stopping Immunotherapy Early Harms NSCLC Patients Who Respond
A randomized Phase 2 trial investigates whether PD-1 inhibitor discontinuation after early response is safe in non-small cell lung cancer.
Clinical Trial
Jun 14, 2026 0
Cancer Research
12-Week Exercise Program Targets Body Composition in Breast Cancer Survivors
A completed trial examines how structured exercise reshapes body composition and sustains physical activity habits in breast cancer patients post-diagnosis.
Clinical Trial
Jun 17, 2026 0
Cancer Research
Metronomic Vinorelbine Plus Atezolizumab Tested as Second-Line NSCLC Therapy
A completed Phase 2 trial explores whether low-dose continuous chemotherapy can boost immunotherapy efficacy in advanced lung cancer.
Clinical Trial
Jun 9, 2026 0
Cancer Research
New Cancer Immunotherapy IBI346 Shows Promise in Multiple Myeloma Trial
Small trial tests innovative treatment IBI346 for blood cancer patients who didn't respond to standard therapies.
Clinical Trial
Mar 28, 2026 1
Cancer Research
HDAC Inhibitor Plus Checkpoint Blocker Tested in Advanced Lung Cancer Trial
A phase 1/2 trial combined mocetinostat and durvalumab in 83 patients with advanced solid tumors and NSCLC.
Clinical Trial
May 7, 2026 0
Cancer Research
16-Week Holistic Program Boosts Quality of Life in Cancer Survivors
A pilot trial tested a comprehensive physical, mental, and spiritual intervention for cancer survivors, tracking outcomes at 6 months post-program.
Clinical Trial
May 28, 2026 0
Page 1 of 2Next